At GARDP North America, we develop innovative partnerships to guard the power of antibiotics, so that modern medicine works for you.

“Our organization aims to make sure all people have the right antibiotic treatment when they need it. Antibiotic innovation is vital regardless of market profitability.”

- Dr. Sara Elizabeth Cosgrove, Board Chair, GARDP North America


Founded in 2021, GARDP North America drives innovative solutions to antibiotic resistance in North America. As a member of the Global Antibiotic Research & Development Partnership’s network, we pursue the common goal of accelerating the development and availability of much-needed antibiotic treatments.


We harness the best of public and private sector resources, capacities, and scientific expertise. As a non-profit, we can place public health needs ahead of commercial returns. We work with public and private partners on late-stage drug development. We bring our expertise to the conduct of clinical trials, even in hard-to-reach geographic areas. We further support drug manufacturing and ensure treatments reach the people who need them most.


Partnerships are at the heart of our success in developing new and improved treatments. We are extremely grateful for the commitment of GARDP’s funders in supporting our work to develop new treatments to address the urgent health crisis of antibiotic resistance. Thank you.


Karen M. Linehan

Board Member

Over 30 years of international experience in large pharmaceutical companies.

Paul Model

Board Member

Extensive experience in the fields of drug development, medical technology, and the formation and financing of companies in the fields of pharmaceuticals, biotechnology, and medical devices.

Jimmy Kolker

Board Member

Retired U.S. Ambassador & Former Assistant Secretary for Global Affairs of U.S. Department of Health and Human Services.

Dr. Prabhavathi Fernandes

Board Member and Chair of Scientific Advisory Committee

More than 35 years of experience in drug discovery and development in large pharmaceutical and biotechnology companies.

Dr. Sara Elizabeth Cosgrove

Board Chair

Associate Hospital Epidemiologist and Professor of Medicine at Johns Hopkins Hospital.


Andrew Betts

Executive Director of GARDP North America

Andy joined GARDP NA in August 2022. He previously served as President and CEO of the Polycystic Kidney Disease Foundation based in Kansas City, Missouri, where he was instrumental in helping to secure the first US-approved treatment for a vastly unknown disease, and raised over $70M. Prior to this role, Andy served as the Executive Director for Development at The Salvation Army, Kansas & Missouri, overseeing the development and marketing teams across 28 cities and achieving annual revenues of $50M+.

Subasree Srinivasan

Medical Director

Suba is an experienced infectious disease physician with extensive industry and public health experience. Educated in India, Suba has lived in the U.S. for the last 30 years. She has worked in clinical and public health practice, and has had a number of senior medical and pharmacovigilance roles in drug development in companies such as Pfizer, BMS, and Alexion Pharmaceuticals.